NU
Nunzia Pharmaceutical Company
NUNZ · OTC
$0.00 +0.00% (+$0.00)
Market Cap $43.5K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Stability
19 /100
Unstable Beta -2.87x
Profitable years 0
EPS volatility 202,051.15%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o NUNZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Sara Gonzales
Employees
4
Headquarters
Long Beach